Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4756339
Max Phase: Preclinical
Molecular Formula: C37H47N9O9S
Molecular Weight: 793.90
Molecule Type: Unknown
Associated Items:
ID: ALA4756339
Max Phase: Preclinical
Molecular Formula: C37H47N9O9S
Molecular Weight: 793.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)Nc1cc(NC(=O)CNC(=O)C23CC4CC(CC(C4)C2)C3)cc(C(=O)NCC(=O)NC[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)c1
Standard InChI: InChI=1S/C37H47N9O9S/c38-36(39)44-26-13-24(12-25(14-26)43-31(48)20-42-35(53)37-15-21-9-22(16-37)11-23(10-21)17-37)32(49)41-19-30(47)40-18-28(34(51)52)45-33(50)29-7-4-8-46(29)56(54,55)27-5-2-1-3-6-27/h1-3,5-6,12-14,21-23,28-29H,4,7-11,15-20H2,(H,40,47)(H,41,49)(H,42,53)(H,43,48)(H,45,50)(H,51,52)(H4,38,39,44)/t21?,22?,23?,28-,29-,37?/m0/s1
Standard InChI Key: SQTQEWRATPPDHW-QRFGUKROSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 793.90 | Molecular Weight (Monoisotopic): 793.3217 | AlogP: 0.53 | #Rotatable Bonds: 15 |
Polar Surface Area: 282.08 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.03 | CX Basic pKa: 8.99 | CX LogP: -1.94 | CX LogD: -1.95 |
Aromatic Rings: 2 | Heavy Atoms: 56 | QED Weighted: 0.09 | Np Likeness Score: -1.19 |
1. Sundaram A,Chen C,Isik Reed N,Liu S,Ki Yeon S,McIntosh J,Tang YZ,Yang H,Adler M,Beresis R,Seiple IB,Sheppard D,DeGrado WF,Jo H. (2020) Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness., 30 (22): [PMID:33007395] [10.1016/j.bmcl.2020.127578] |
Source(1):